Cancer T Cell Immunotherapy with Bispecific Antibodies and Chimeric Antigen Receptors

E-ISSN： 2212-3970|8|3|239-254

ISSN： 1574-8928

Source： Recent Patents on Anti-Cancer Drug Discovery, Vol.8, Iss.3, 2013-09, pp. : 239-254

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A highly effective and stable bispecific diabody for cancer immunotherapy: cure of xenografted tumors by bispecific diabody and T-LAK cells

By Hayashi Hiroki Asano Ryutaro Tsumoto Kouhei Katayose Yu Suzuki Masanori Unno Michiaki Kodama Hideaki Takemura Shin-ichi Yoshida Hiroshi Makabe Koki Imai Kohzoh Matsuno Seiki Kumagai Izumi Kudo Toshio

Cancer Immunology, Immunotherapy, Vol. 53, Iss. 6, 2004-06 ,pp. : 497-509

Springer Publishing Company

Access to resources Recommend Favorite

A bispecific diabody directed against prostate-specific membrane antigen and CD3 induces T-cell mediated lysis of prostate cancer cells

By Bühler P. Wolf P. Gierschner D. Schaber I. Katzenwadel A. Schultze-Seemann W. Wetterauer U. Tacke M. Swamy M. Schamel W. Elsässer-Beile U.

Cancer Immunology, Immunotherapy, Vol. 57, Iss. 1, 2008-01 ,pp. : 43-52

Springer Publishing Company

Access to resources Recommend Favorite

Regional Delivery of Chimeric Antigen Receptor (CAR) T-Cells for Cancer Therapy

By Sridhar Praveen Petrocca Fabio

Cancers, Vol. 9, Iss. 7, 2017-07 ,pp. : 92-92

MDPI

Access to resources Recommend Favorite

Recent Advances in T Cell Adoptive Immunotherapy of Cancer

Current Cancer Therapy Reviews, Vol. 4, Iss. 1, 2008-02 ,pp. : 1-13

Bentham Science Publishers

Access to resources Recommend Favorite

Impaired surface antigen presentation in tumors: implications for T cell-based immunotherapy

By Ruiz-Cabello F. Cabrera T. Lopez-Nevot M-A. Garrido F.

Seminars in Cancer Biology, Vol. 12, Iss. 1, 2002-02 ,pp. : 403-405

Academic Press

Access to resources Recommend Favorite